The gospel of diabetics: Artificial intelligence is no worse than doctors

for patients with type 1 diabetes, intensive insulin therapy is a standard treatment that can effectively reduce the risk of complications. However, their demand for insulin doses changes so quickly that it is often difficult to regulate insulin pumps so frequently. This allows less than a third of patients to meet their blood sugar management goals.So can artificial intelligence be used to help patients adjust insulin doses? The Moshe Phillip team at schneider Children's Medical Center in Israel tested the effects of insulin dose regulation in decision support systems (AI-DSS) based on automated artificial intelligence, and their research was entitled "Insulin dose optimization using an automatedartificial intelligence-base support system in youths with type 1diabetes", published in the internationally renowned academic journal Nature-Medicine on September 9, 2020.This multi-center, transnational, parallel, randomized, non-inefficient study is called ADVICE4U. The study included 108 patients aged 10-21 with type 1 diabetes treated with insulin pumps for a period of 6 months.The patients were randomly divided into two groups, adjusting the insulin dose every three weeks. Among them, one group received insulin dose adjustment for AI-DSS for AI-DSS group, and the other group adjusted for physician-directed group. The researchers found no significant difference between the two groups of patients with a reading of 54 mg/dl (<3.0mmoll-1). However, three adverse events (two severe hypoglycemia and one diabetic ketoacidosis) occurred in patients in the physician group, which was not reported by the AI-DSS group.All in all, the study of this non-inefficient design produced positive results: using artificial intelligence to adjust insulin pumps was no less than that of professional endocrinologists.At present, more and more patients rely on insulin pumps for treatment, but there is a relative shortage of professional endocrinologists. For patients who need to adjust insulin pump settings frequently, this study provides a new solution that is a boon for people with diabetes. (Biological Exploration): Insulin dose optimization using an automated peopleintelligence-base support system with type 1 diabetes